Establishment Labs HoldingsESTA -0.83%75 Cyclically Adjusted PS Ratio is 16.99 as of Jul. 11, 2026, which is 29% above its 10-year median of 13.19. GuruFocus rates ESTA with a GF Score™ of 75/100 and a GF Value™ of $61.83 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 523 Medical Devices & Instruments companies, Establishment Labs Holdings ranks worse than 94.07% on this metric.
The historical rank and industry rank for Establishment Labs Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:
ESTA'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 10.68 Med: 13.19 Max: 17.13
Current: 17.13
During the past 10 years, Establishment Labs Holdings's highest Cyclically Adjusted PS Ratio was 17.13. The lowest was 10.68. And the median was 13.19.
ESTA's Cyclically Adjusted PS Ratio is ranked worse than 94.07% of 523
companies
in the Medical Devices & Instruments industry
Industry Median: 2.32
vs ESTA: 17.13
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Establishment Labs Holdings's adjusted revenue per share data of for the fiscal year that ended in Dec25 was $7.126. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.18 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Establishment Labs Holdings (NAS:ESTA) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Establishment Labs Holdings Cyclically Adjusted PS Ratio Related Terms
Establishment Labs Holdings Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Establishment Labs Holdings Cyclically Adjusted PS Ratio Chart
ESTA vs AXGN, TMDX, BFLY: Cyclically Adjusted PS Ratio Comparison
For the Medical Devices subindustry, Establishment Labs Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Establishment Labs Holdings Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Establishment Labs Holdings's Cyclically Adjusted PS Ratio falls into.
Establishment Labs Holdings Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 16.99 mean?
Establishment Labs Holdings (ESTA) has a Cyclically Adjusted PS Ratio of 16.99 as of Jul. 11, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Establishment Labs Holdings and its competitors. This is 29% above median its historical median of 13.19. Over the past decade, Establishment Labs Holdings' Cyclically Adjusted PS Ratio has ranged from 10.68 to 17.13. According to the industry distribution chart, Establishment Labs Holdings ranks #492 out of 523 companies in the Medical Devices & Instruments industry, placing it in the top 94.1%.
Is Establishment Labs Holdings' Cyclically Adjusted PS Ratio too high?
Establishment Labs Holdings' current Cyclically Adjusted PS Ratio of 16.99 is 29% above median its 10-year median of 13.19. Over the past 10 years, this metric has ranged from a low of 10.68 to a high of 17.13. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.32. Establishment Labs Holdings' value of 16.99 is 632.3% above this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #492 out of 523 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Establishment Labs Holdings has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' Cyclically Adjusted PS Ratio compare to AXGN and TMDX?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #492 out of 523 companies for Cyclically Adjusted PS Ratio. This places Establishment Labs Holdings in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 2.32. Establishment Labs Holdings' value of 16.99 is 632.3% above this benchmark. Historically, Establishment Labs Holdings' own Cyclically Adjusted PS Ratio has ranged from 10.68 to 17.13 over the past decade. While the company's 10-year median is 13.19 vs. the industry median of 2.32, Establishment Labs Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.32, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current Cyclically Adjusted PS Ratio of 16.99 is 632.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current Cyclically Adjusted PS Ratio is 16.99, which is 29% above median its own 10-year median of 13.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.83, compared to a current price of $88.03 — trading 42.4% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 16.99, which is 29% above median its 10-year median of 13.19 and 632.3% above the Medical Devices & Instruments industry median of 2.32. Establishment Labs Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current Cyclically Adjusted PS Ratio is 16.99 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Establishment Labs Holdings (ESTA) Overvalued in 2026?
Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued.
The current stock price of $88.03 is trading 42.4% above its estimated GF Value™ of $61.83.
GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.
Key valuation signals for ESTA:
Cyclically Adjusted PS Ratio: 16.99 (29% above median its 10-year median of 13.19)
GF Value™: $61.83 vs. price of $88.03 (42.4% above fair value)
Industry Position: 632.3% above the Medical Devices & Instruments median (#492 of 523)
No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
75GF Score
Get the complete analysis for ESTA
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESTA has been successfully added to your 
